Valneva (ADR) (VALN)
Develops, manufactures, and sells travel vaccines alongside infectious-disease vaccine programs.
$6.64
vs last close+0.02 (+0.30%)
Something off on this page? Send us feedback.
Next report
Nov 19, 26
in 58 days
EPS estimate
−$0.17
Revenue estimate
$43.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.54−$0.13−$0.16−$0.61−$0.68−$0.42−$0.40Pending
Estimate−$0.22−$0.31−$0.27−$0.30−$0.17−$0.21−$0.28−$0.17
Surprise−145.5%+58.1%+40.7%−103.3%−293.1%−100.0%−42.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$54.8M$54.0M$56.9M$34.4M$55.9M$36.2M$40.3MPending
Estimate$36.7M$44.5M$39.1M$48.9M$52.5M$54.7M$48.2M$43.8M
Surprise+49.4%+21.3%+45.5%−29.5%+6.5%−33.8%−16.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.08 | — | — |
| Sep 2027 | −$0.20 | — | — |
| Jun 2027 | −$0.32 | — | — |
| Mar 2027 | −$0.32 | — | — |
| Dec 2026 | −$0.05 | — | — |
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$0.28 | −$0.40 | −42.9% |
| May 2026 | −$0.21 | −$0.42 | −100.0% |
| Mar 2026 | −$0.17 | −$0.68 | −293.1% |
| Nov 2025 | −$0.30 | −$0.61 | −103.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| May 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.08 | — | — | $75.3M | — | — | — |
| Sep 2027 | −$0.20 | — | — | $48.3M | — | — | — |
| Jun 2027 | −$0.32 | — | — | $38.2M | — | — | — |
| Mar 2027 | −$0.32 | — | — | $38.2M | — | — | — |
| Dec 2026 | −$0.05 | — | — | $46.1M | — | — | — |
| Nov 19, 2026 | −$0.17 | — | — | $43.8M | — | — | — |
| Aug 13, 2026 | −$0.28 | −$0.40 | −42.9% | $48.2M | $40.3M | −16.4% | +1.8% |
| May 13, 2026 | −$0.21 | −$0.42 | −100.0% | $54.7M | $36.2M | −33.8% | −2.2% |
| Mar 16, 2026 | −$0.17 | −$0.68 | −293.1% | $52.5M | $55.9M | +6.5% | −0.9% |
| Nov 20, 2025 | −$0.30 | −$0.61 | −103.3% | $48.9M | $34.4M | −29.5% | −2.0% |
| Aug 12, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Sep 21, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 18, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 20, 2021 | |||||||
| May 7, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |